Soluble HLA G serum levels in patients with the Acquired Immunodeficiency Syndrome affected by different AIDS-defining conditions before and after anti-retroviral treatment

• Published in: Journal of Biological Research Vol. 84; no. 1; p. 144
• Main Authors: Murdaca, G, Cagnati, P, Puppo, F
• Format: Journal Article
• Language: English
• Published: Pavia PAGEPress Publications 01-01-2011
• Subjects: Human immunodeficiency virus
• ISSN: 1826-8838; 2284-0230
• DOI: 10.4081/jbr.2011.4656

We have previously reported that serum levels of soluble HLA-A,-B,-C and -G antigens are elevated in HIV-infected subjects and decrease after antiretroviral therapy. In this study we measured soluble HLA-G serum levels in patients with AIDS affected by different AIDS-defining conditions before and during antiretroviral therapy and correlated them with virological and immunological parameters. Soluble HLA-G levels were significantly higher in AIDS patients before treatment as compared to healthy controls and significantly decreased after of 36 months of therapy, correlating with the decrease of plasma HIV-RNA level and CD8+ T-lymphocytes number and with the increase of CD4+ T-lymphocytes number. Soluble HLA-G levels were significantly higher in patients with opportunistic infections and Kaposi's sarcoma as compared with those with wasting syndrome. These data suggest that infections and neoplasms may trigger the shedding of soluble HLA-G molecules and confirm that the level of soluble HLA-G in serum might represent a surrogate marker to monitor virological response and immune reconstitution in HIV-positive subjects.